tci Medicare Compliance & Reimbursement - 2007 Issue 32
PART D: Off-Label Coverage War Heats Up
Subscribe or sign in to view the full article.
Article Overview
This article discusses a Medicare Part D coverage controversy centered on off-label prescription drug use and how a federal rule is being interpreted in relation to established compendia. It explains why the issue matters for pharmacists, beneficiaries, and advocates who handle denials, exceptions, and appeals, and it references commentary from CMS, the Medicare Rights Center, and a medical journal example.
Why This Topic Matters
The topic affects whether certain prescriptions may be covered under Medicare Part D and highlights a policy dispute that can influence pharmacy claims, beneficiary access, and appeal activity.
What You Will Learn
- How Medicare Part D coverage disputes can arise for off-label prescriptions
- Why medical compendia are central to the coverage debate
- What pharmacists and advocates may consider when responding to denials
- How CMS, the Medicare Rights Center, and other sources frame the issue
Who Should Read This
- Pharmacists
- Pharmacy managers
- Medical coders
- Billing and reimbursement staff
- Medicare advocates
- Healthcare compliance professionals
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com